Page last updated: 2024-09-04

jte 522 and Carcinoma, Squamous Cell

jte 522 has been researched along with Carcinoma, Squamous Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawakami, K; Mizuno, H; Nishimura, G; Tsukuda, M; Yanoma, S1

Other Studies

1 other study(ies) available for jte 522 and Carcinoma, Squamous Cell

ArticleYear
A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells.
    Japanese journal of cancer research : Gann, 1999, Volume: 90, Issue:10

    Topics: Animals; Benzenesulfonates; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytotoxicity, Immunologic; Female; G1 Phase; Head and Neck Neoplasms; Humans; Isoenzymes; KB Cells; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Membrane Proteins; Mice; Mice, Nude; Oxazoles; Platelet-Derived Growth Factor; Prostaglandin-Endoperoxide Synthases; Telomerase; Transplantation, Heterologous

1999